Literature DB >> 22257501

A novel mutation in SCN4A causes severe myotonia and school-age-onset paralytic episodes.

Harumi Yoshinaga1, Shunichi Sakoda, Jean-Marc Good, Masanori P Takahashi, Tomoya Kubota, Eri Arikawa-Hirasawa, Tomohiko Nakata, Kinji Ohno, Tetsuro Kitamura, Katsuhiro Kobayashi, Yoko Ohtsuka.   

Abstract

Mutations in the pore-forming subunit of the skeletal muscle sodium channel (SCN4A) are responsible for hyperkalemic periodic paralysis, paramyotonia congenita and sodium channel myotonia. These disorders are classified based on their cardinal symptoms, myotonia and/or paralysis. We report the case of a Japanese boy with a novel mutation of SCN4A, p.I693L, who exhibited severe episodic myotonia from infancy and later onset mild paralytic attack. He started to have apneic episodes with generalized hypertonia at age of 11 months, then developed severe episodic myotonia since 2 years of age. He presented characteristic generalized features which resembled Schwarz-Jampel syndrome. After 7 years old, paralytic episodes occurred several times a year. The compound muscle action potential did not change during short and long exercise tests. Functional analysis of the mutant channel expressed in cultured cell revealed enhancement of the activation and disruption of the slow inactivation, which were consistent with myotonia and paralytic attack. The severe clinical features in his infancy may correspond to myotonia permanence, however, he subsequently experienced paralytic attacks. This case provides an example of the complexity and overlap of the clinical features of sodium channel myotonic disorders.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22257501     DOI: 10.1016/j.jns.2011.12.015

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Focal and abnormally persistent paralysis associated with congenital paramyotonia.

Authors:  Armelle Magot; Albert David; Damien Sternberg; Yann Péréon
Journal:  BMJ Case Rep       Date:  2014-06-17

2.  Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.

Authors:  Jean-François Desaphy; Concetta Altamura; Savine Vicart; Bertrand Fontaine
Journal:  J Neuromuscul Dis       Date:  2021

3.  Kinetic Alterations in Resurgent Sodium Currents of Mutant Nav1.4 Channel in Two Patients Affected by Paramyotonia Congenita.

Authors:  Ming-Jen Lee; Pi-Chen Lin; Ming-Hong Lin; Hsin-Ying Clair Chiou; Kai Wang; Chiung-Wei Huang
Journal:  Biology (Basel)       Date:  2022-04-18

4.  Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.

Authors:  Silvia Corrochano; Roope Männikkö; Peter I Joyce; Philip McGoldrick; Jessica Wettstein; Glenda Lassi; Dipa L Raja Rayan; Gonzalo Blanco; Colin Quinn; Andrianos Liavas; Arimantas Lionikas; Neta Amior; James Dick; Estelle G Healy; Michelle Stewart; Sarah Carter; Marie Hutchinson; Liz Bentley; Pietro Fratta; Andrea Cortese; Roger Cox; Steve D M Brown; Valter Tucci; Henning Wackerhage; Anthony A Amato; Linda Greensmith; Martin Koltzenburg; Michael G Hanna; Abraham Acevedo-Arozena
Journal:  Brain       Date:  2014-10-27       Impact factor: 13.501

Review 5.  Cellular hyper-excitability caused by mutations that alter the activation process of voltage-gated sodium channels.

Authors:  Mohamed-Yassine Amarouch; Hugues Abriel
Journal:  Front Physiol       Date:  2015-02-17       Impact factor: 4.566

6.  Changes of Resurgent Na+ Currents in the Nav1.4 Channel Resulting from an SCN4A Mutation Contributing to Sodium Channel Myotonia.

Authors:  Chiung-Wei Huang; Hsing-Jung Lai; Pi-Chen Lin; Ming-Jen Lee
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

7.  Changes in Resurgent Sodium Current Contribute to the Hyperexcitability of Muscles in Patients with Paramyotonia Congenita.

Authors:  Chiung-Wei Huang; Hsing-Jung Lai; Pi-Chen Lin; Ming-Jen Lee
Journal:  Biomedicines       Date:  2021-01-08

Review 8.  Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison.

Authors:  Gildas Loussouarn; Damien Sternberg; Sophie Nicole; Céline Marionneau; Francoise Le Bouffant; Gilles Toumaniantz; Julien Barc; Olfat A Malak; Véronique Fressart; Yann Péréon; Isabelle Baró; Flavien Charpentier
Journal:  Front Pharmacol       Date:  2016-01-14       Impact factor: 5.810

9.  Dysfunction of NaV1.4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study.

Authors:  Roope Männikkö; Leonie Wong; David J Tester; Michael G Thor; Richa Sud; Dimitri M Kullmann; Mary G Sweeney; Costin Leu; Sanjay M Sisodiya; David R FitzPatrick; Margaret J Evans; Iona J M Jeffrey; Jacob Tfelt-Hansen; Marta C Cohen; Peter J Fleming; Amie Jaye; Michael A Simpson; Michael J Ackerman; Michael G Hanna; Elijah R Behr; Emma Matthews
Journal:  Lancet       Date:  2018-04-05       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.